GAS5 long Noncoding RNA regulates CD20 expression and rituximab response
These findings highlight a complex interplay between GAS5, CD20, rituximab, and cellular pathways, underscoring the significance of understanding these interactions to enhance cancer therapy outcomes.
Authors
- Mahbubeh Rojhannezhad (ORCID: https://orcid.org/0000-0001-8897-4528)
- Zahra Abedi Kichi (ORCID: https://orcid.org/0000-0003-2634-0591)
- Mehrdad Behmanesh (ORCID: https://orcid.org/0000-0002-3901-304X)
- Abbas Nikravesh (ORCID: https://orcid.org/0000-0002-3543-7291)
Institutions
- Tarbiat Modares University (IR)
- North Khorasan University of Medical Sciences (IR)
- Ludwig-Maximilians-Universität München (DE)
Publication Details
- Journal
- Advanced Pharmaceutical Bulletin
- Published
- 2025-10-11
- DOI
- https://doi.org/10.34172/apb.025.45822
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 0.00